A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors

Wang, WQ; Zhang, WH; Gao, HL; Huang, D; Xu, HX; Li, S; Li, TJ; Xu, SS; Li, H; Long, J; Ye, LY; Wu, CT; Han, X; Wang, XH; Liu, L; Yu, XJ

Liu, L; Yu, XJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China.; Liu, L; Yu, XJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Liu, L; Yu, XJ (corresponding author), Shanghai Pancreat Canc Inst, Shanghai, Peoples R China.; Liu, L; Yu, XJ (corresponding author), Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China.

JOURNAL OF GASTROENTEROLOGY, 2021; 56 (4): 395

Abstract

Background Pancreatic neuroendocrine tumors (PanNETs) are indolent pancreatic tumors derived from neuroendocrine cells in pancreatic islets. To date, ......

Full Text Link